🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Poland / NCT06718036
Enrolling by invitation Observational

Validation and Evaluation of the ICF Rehabilitation Set

NCT06718036 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2024-12-15
Last updated
2025-03-26

Condition(s) studied

Chronic Disease

Investigational drug(s) / intervention(s)

Validation and evaluation of the use of the ICF Rehabilitation Set in clinical practice

Validation and evaluation of the use of the ICF Rehabilitation Set in clinical practice: Validation and evaluation of the use of the ICF Rehabilitation Set in clinical practice

Study summary

Rehabilitation is considered a key health strategy in the 21st century. The aim of rehabilitation is to optimize the functioning of patients. The International Classification of Functioning, Disability and Health (ICF) is a framework for describing and organizing information on functioning and disability. Therefore, the aim of the study is to validate and evaluate the application of the ICF Rehabilitation Set in Polish clinical practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Presence of chronic diseases, including: neurological, cardiological, pulmonary and musculoskeletal problems. * Cognitive state, enabling to answer questions reliably and accurately, minimum 6 points on the AMTS scale * Adults participating in the rehabilitation process * Consent to participate in the study. Exclusion Criteria: * Previous surgeries, with surgical intervention. * Fractures. * Severe systemic diseases that prevent the examination, e.g. acute neoplastic disease, exacerbation of chronic diseases, infections.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Rzeszow Rzeszów Poland

More University of Rzeszow trials in Poland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06718036 on ClinicalTrials.gov ↗ ← All trials in Poland